| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 1995;26:2027-2030.)
© 1995 American Heart Association, Inc.
Articles |
From the Departments of Neurology (R. de H., M.L.) and Clinical Epidemiology and Biostatistics (R. de H., P.B.), Academic Medical Center, University of Amsterdam; the Center for Clinical Decision Sciences (J. van der M.), Erasmus University, Rotterdam; and The Amsterdam World Health Organization Collaborating Center on Quality of Life, The Netherlands Cancer Institute, (N.A.), Amsterdam, the Netherlands.
Correspondence to Dr R. de Haan, Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands.
| Abstract |
|---|
|
|
|---|
Methods We studied 438 patients 6 months after stroke. Data were collected on the following functional health indicators: alertness, communication, independence, disability in activities of daily living, mobility, instrumental disability, social interaction, and recreation. Disability in activities of daily living was assessed with the Barthel Index, whereas the other indicators were measured with subscales of the Sickness Impact Profile. The association between functional health and Rankin Scale was expressed in terms of relative frequencies and Somers' D statistic. Linear regression analysis (after ordinal transformation) was used to identify the significant health factors that explain Rankin scores.
Results Mobility, disability in daily and instrumental activities, and living arrangements showed a stronger association with Rankin scores (Somers' D range, 0.60 to 0.74) than cognitive and social functioning (Somers' D range, 0.34 to 0.47). Disability in activities of daily living turned out to be the most important explanatory factor of Rankin scores (R2=67%).
Conclusions The Rankin Scale is not a pure handicap measure but should be viewed as a global functional health index with a strong accent on physical disability. The index is useful as a simple and time-efficient outcome measure in large-scale multicenter trials. It is argued that at present there is no clear need to assess handicap as the primary outcome in medically oriented stroke intervention studies.
Key Words: disability evaluation stroke assessment stroke outcome quality of life
| Introduction |
|---|
|
|
|---|
In the past years, many health indexes have been constructed within this conceptual framework. Most of these instruments focus on impairments (eg, dysarthria, ataxia, and hemianopsia), disabilities in activities of daily living (ADL) (eg, bathing, dressing, and toileting), and instrumental disabilities (eg, meal preparation, shopping, and outdoor mobility).
Of the few available handicap instruments, the Rankin Scale is without doubt the most well-known measure in stroke outcome research.2 The original index was a 5-point rating scale that graded patients on their overall level of independence with reference to previous activities. Although the reliability of the Rankin Scale in terms of interobserver agreement and reproducibility has been evaluated with satisfactory results,3 4 relatively little is known about the validity of the index. One of the main objections to the Rankin Scale is that it does not rate handicap but rather disability.5 In the original scale, for example, the word "disability" was used, whereas the ability to walk was an explicit grading criterion. To overcome this conceptual problem, the original scale has been modified by replacing the word "disability" by "handicap," by introducing the term "lifestyle" into the scoring categories, and by deleting ambulation as a scoring indicator.6
The present study was undertaken to investigate the clinical meaning of Rankin grades by identifying which aspects of cognitive, physical, and social health domains are associated with Rankin scores.
| Subjects and Methods |
|---|
|
|
|---|
Six months after the stroke, patients were interviewed by trained research assistants using a semistructured questionnaire. One hundred twelve patients (26%) were not able to communicate because of severe speech, language, or cognitive disorders. These latter patients were rated by a proxy respondent (most typically the partner). During the interviewer training, it was stressed that any limitations in the patient's social role functioning should be assessed.
Interview data were collected on the following indicators of functional health: cognitive alertness behavior and ability to communicate; level of disability in ADL, mobility, and extended daily activities (instrumental disability); patients' present living arrangements; and limitations in social interactions and recreation. These cognitive, physical, and social indicators approximately reflect the formal ICIDH handicap dimensions: orientation handicap, physical independence handicap, mobility handicap, and social integration handicap.1 Since only a minority of the patients (20%) were employed at stroke onset, we did not focus on indicators that reflect the occupation and economic self-sufficiency handicap dimensions.
ADL disability was assessed with the Barthel Index,7 whereas cognitive alertness behavior, ability to communicate, mobility, instrumental disability, social interaction, and recreation were measured with subscales of the Sickness Impact Profile (SIP).8 On the basis of this information, the interviewer scored the patient's level of handicap with the modified Rankin Scale.6
To evaluate the meaning of Rankin grades, the associations between the
functional health indicators and the Rankin Scale were examined. To
enhance the comparability between the various (sub)scales, we divided
the indicator scores into three categories. SIP scores were categorized
as mildly (score
median), moderately (score >median and
75th
percentile), and severely (score >75th percentile) limited. Barthel
Index scores were classified as no disability (score=20), mild
disability (score
10 and <20), and severe disability (score <10).
Patients' living arrangements were divided into independent,
rehabilitation center, and nursing home categories. The association
between indicator scores and Rankin scores was expressed in terms of
relative frequencies and Somers' D statistic. Somers' D is an
asymmetrical index of relation between one ordered independent
variable and another ordered dependent variable, and it ranges
in values between -1 and +1.9 The extremes
reflect a perfect association, whereas the value 0 indicates an absence
of association. We assumed that, for the Rankin Scale to be a valid
handicap index, not only the physical but also the cognitive and social
indicators had to associate substantially with the Rankin Scale.
Because it was expected that various aspects of functional health would be interrelated (eg, ADL disability, mobility, living arrangements, and social integration), the association of functional health indicators with Rankin scores was also analyzed with linear regression analysis. Because of the ordinal characteristic of the Rankin Scale, an ordinal transformation of the Rankin scores was performed (using the SAS procedure TRANSREG). The indicator scores were treated as continuous variables. In this analysis all variables were included into the model.
| Results |
|---|
|
|
|---|
The majority of the patients (62%) scored in the middle range of the
Rankin Scale (minor or moderate handicap), whereas only a few patients
(7%) were grouped in the extreme score categories. The median Rankin
score was 3 (Table 1
).
|
The association between functional health indicators and Rankin Scale
scores is presented in Table 2
. Patients who
were mildly disabled in cognitive, physical, and social functions, as
well as those who were living independently, had higher relative
frequencies of Rankin categories 0, 1, and 2. An opposite pattern was
seen in the patients with serious cognitive impairments or social
limitations. These patients had higher relative frequencies of Rankin
grades 3, 4, or 5. Patients with severe disability in mobility and
(extended) daily activities showed a somewhat different picture. These
physically disabled patients were clustered more frequently in the
fourth and fifth Rankin scoring category. Most of the severely affected
patients were living in nursing homes. In general, the moderately
disabled patients were clustered in Rankin category 3. Mobility, ADL
and instrumental activities, and living arrangement were more highly
associated with Rankin grades (Somers' D range, 0.60 to 0.74) than the
level of cognitive and social dysfunction (Somers' D range, 0.34 to
0.47).
|
A linear model to identify which aspects of functional health
were associated most with Rankin scores (after ordinal transformation)
is presented in Table 3
. Seventy-eight
percent of the total variation of Rankin scores could be explained by
the fitted model. ADL disability and, to a much lesser extent,
instrumental disability and living arrangement were the most important
factors; together they explained 76% of the total variance of Rankin
scores. Separate analyses in our sample did not show a
significant difference of regression results between patients with and
without the ability to communicate.
|
| Discussion |
|---|
|
|
|---|
Univariate analysis showed pronounced associations between (complex) daily activities, mobility, and living arrangement on the one hand and Rankin grades on the other. Multivariate analysis largely supported these findings. Disability in ADL and, to a considerably lesser extent, instrumental disability and living arrangement were found to be the most important factors associated with Rankin scores. The other indicators, including the cognitive and social health domains, did not explain variation in Rankin scores. In other words, Rankin scores appear to reflect primarily a global level of disability rather than handicap.
During interviewer training, the importance of considering patients' level of social role functioning in generating Rankin scores was stressed. Additionally, particular attention was given to the conceptual difference between disability and handicap in general as well as the scoring of disability instruments and the Rankin Scale in particular. Nevertheless, the present results indicate that to broaden the scope of the Rankin Scale (or of the interviewer) to include more handicap-related health aspects one probably has to introduce more nuances in the globally defined Rankin scoring categories and introduce a standardized observational procedure.
Before discussing the usefulness of the Rankin Scale in stroke outcome studies, two questions related to the concept of handicap need to be addressed: (1) What precisely is meant by handicap? and (2) Should we focus on this concept in stroke medical-intervention studies?
As has been noted previously, impairment and disability are currently better conceptualized than handicap.10 The ICIDH scheme defines handicap as the disadvantageous situation of an impaired or disabled patient that prevents him from fulfilling survival roles. However, the ICIDH indicators of the handicap dimension do not refer explicitly to the patient's circumstances and situation but rather to his functional abilities, activities, and competence (eg, physical independence, mobility, and the ability to work).11 12 As long as the handicap section of the ICIDH contains such confusing disability-related elements, problems will remain in constructing indexes to measure distinct aspects of handicap and disability.
The extent to which an impaired and disabled stroke patient fulfills normally expected social roles and relates adequately with his social environment is of major importance for his overall quality of life. For a patient whose medical treatment has reached its limits, the quality of life can probably be improved only by reducing handicap.13 Assessment of the individual patient's level of handicap is therefore particularly relevant in rehabilitation settings. Other areas in which the concept of handicap can be used meaningfully are evaluation of a patient's need for nonmedical care services, care planning, and healthcare policy. Handicap, however, is extremely broadly defined and therefore difficult to measure. In this context, Wade14 outlines three major problems: (1) Handicap has to be assessed with reference to specific culturally based expectations of the individual patient, so there is no absolute standard for judging handicap; (2) Since handicap arises from the interaction between disability and environment, it is also necessary to assess the patient's environment (eg, public attitudes and economic aspects); and (3) In contrast to disability, which refers to skills and behaviors, handicap cannot be observed directly. In view of these problems, we feel that at present handicap is not specifically the field of the physician and that, in the evaluation of medical treatments for stroke patients, physicians should generally not focus on handicap as a primary outcome but on a more tangible manifestation of disease in terms of disability.
Despite its modifications, the Rankin Scale should not be viewed as a pure handicap measure but rather as a global functional health index with a strong accent on physical disability. That is not to say that the Rankin Scale has no value in stroke outcome research. To the contrary, the index can be used as an efficient tool to describe global functional health levels. The index is also useful as a simple and time-efficient functional outcome measure in large-scale multicenter trials. In the latter case, for example, Rankin scores can be divided into two frequently used scoring categories, grades 0 to 3 (reflecting mild to moderate disablement) and grades 4 and 5 (referring to severe disablement), such that an intervention effect can be expressed in terms of "relative risk." Our results support the validity of such a dichotomy.
To summarize, although there are significant associations between various functional health indicators and Rankin grades, our study indicates that physical disability is by far the most important health factor associated with Rankin grades. Nevertheless, the index can be used as an efficient global functional outcome index after stroke. At this moment, there is no clear need to assess handicap as the primary outcome in medically oriented stroke intervention studies.
| Acknowledgments |
|---|
Received March 23, 1995; revision received July 25, 1995; accepted July 27, 1995.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Paciaroni, G. Agnelli, F. Corea, W. Ageno, A. Alberti, A. Lanari, V. Caso, S. Micheli, L. Bertolani, M. Venti, et al. Early Hemorrhagic Transformation of Brain Infarction: Rate, Predictive Factors, and Influence on Clinical Outcome: Results of a Prospective Multicenter Study Stroke, August 1, 2008; 39(8): 2249 - 2256. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bernhardt, H. Dewey, A. Thrift, J. Collier, and G. Donnan A Very Early Rehabilitation Trial for Stroke (AVERT): Phase II Safety and Feasibility Stroke, February 1, 2008; 39(2): 390 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Van der Heyden, M. J. Suttorp, E. T. Bal, J. M. Ernst, R. G. Ackerstaff, J. Schaap, J. C. Kelder, M. Schepens, and H. W. Plokker Staged Carotid Angioplasty and Stenting Followed by Cardiac Surgery in Patients With Severe Asymptomatic Carotid Artery Stenosis: Early and Long-Term Results Circulation, October 30, 2007; 116(18): 2036 - 2042. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kunte, S. Schmidt, M. Eliasziw, G. J. del Zoppo, J. M. Simard, F. Masuhr, M. Weih, and U. Dirnagl Sulfonylureas Improve Outcome in Patients With Type 2 Diabetes and Acute Ischemic Stroke Stroke, September 1, 2007; 38(9): 2526 - 2530. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fernandez, J. M. Schmidt, J. Claassen, M. Pavlicova, D. Huddleston, K. T. Kreiter, N. D. Ostapkovich, R. G. Kowalski, A. Parra, E. S. Connolly, et al. Fever after subarachnoid hemorrhage: Risk factors and impact on outcome Neurology, March 27, 2007; 68(13): 1013 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Banks and C. A. Marotta Outcomes Validity and Reliability of the Modified Rankin Scale: Implications for Stroke Clinical Trials: A Literature Review and Synthesis Stroke, March 1, 2007; 38(3): 1091 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Sylaja, S. B. Coutts, S. Subramaniam, M. D. Hill, M. Eliasziw, A. M. Demchuk, and for the VISION Study Group Acute ischemic lesions of varying ages predict risk of ischemic events in stroke/TIA patients Neurology, February 6, 2007; 68(6): 415 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
I van Wijk, E Lindeman, L J Kappelle, J van Gijn, P J Koudstaal, J W Gorter, A Algra, and for the LiLAC Study Group* Functional status and use of healthcare facilities in long-term survivors of transient ischaemic attack or minor ischaemic stroke J. Neurol. Neurosurg. Psychiatry, November 1, 2006; 77(11): 1238 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Meschia, L. D. Case, B. B. Worrall, R. D. Brown Jr, T. G. Brott, M. Frankel, S. Silliman, S. S. Rich, and for the Ischemic Stroke Genetics Study Group Family history of stroke and severity of neurologic deficit after stroke Neurology, October 24, 2006; 67(8): 1396 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Boulanger, S. B. Coutts, M. Eliasziw, A.J. Gagnon, J. E. Simon, S. Subramaniam, C.-H. Sohn, J. Scott, A. M. Demchuk, and for the VISION Study Group Cerebral Microhemorrhages Predict New Disabling or Fatal Strokes in Patients With Acute Ischemic Stroke or Transient Ischemic Attack Stroke, March 1, 2006; 37(3): 911 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hartmann, H. Mast, J. P. Mohr, J. Pile-Spellman, E. S. Connolly, R. R. Sciacca, A. Khaw, and C. Stapf Determinants of Staged Endovascular and Surgical Treatment Outcome of Brain Arteriovenous Malformations Stroke, November 1, 2005; 36(11): 2431 - 2435. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Hadjigeorgiou, K. Paterakis, E. Dardiotis, M. Dardioti, K. Aggelakis, A. Tasiou, G. Xiromerisiou, A. Komnos, E. Zintzaras, N. Scarmeas, et al. IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury Neurology, October 11, 2005; 65(7): 1077 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Uyttenboogaart, R. E. Stewart, P. C.A.J. Vroomen, J. De Keyser, and G.-J. Luijckx Optimizing Cutoff Scores for the Barthel Index and the Modified Rankin Scale for Defining Outcome in Acute Stroke Trials Stroke, September 1, 2005; 36(9): 1984 - 1987. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Etgen, H. Baum, K. Sander, and D. Sander Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide in Acute Ischemic Stroke Do Not Relate to Clinical Prognosis Stroke, February 1, 2005; 36(2): 270 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Qureshi, Y. M. Mohammad, A. M. Yahia, J. I. Suarez, A. M. Siddiqui, J. F. Kirmani, M. F. K. Suri, J. Kolb, and O. O. Zaidat A Prospective Multicenter Study to Evaluate the Feasibility and Safety of Aggressive Antihypertensive Treatment in Patients With Acute Intracerebral Hemorrhage J Intensive Care Med, January 1, 2005; 20(1): 34 - 42. [Abstract] [PDF] |
||||
![]() |
A. Rufa, M. T. Dotti, P. Frezzotti, N. De Stefano, A. Caporossi, and A. Federico Hemodynamic Evaluation of the Optic Nerve Head in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Arch Neurol, August 1, 2004; 61(8): 1230 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tuominen, Q. Miao, T. Kurki, S. Tuisku, M. Poyhonen, H. Kalimo, M. Viitanen, H. T. Sipila, J. Bergman, and J. O. Rinne Positron Emission Tomography Examination of Cerebral Blood Flow and Glucose Metabolism in Young CADASIL Patients Stroke, May 1, 2004; 35(5): 1063 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gupta, H.C. Schumacher, S. Mangla, P.M. Meyers, H. Duong, A.G. Khandji, R.S. Marshall, J.P. Mohr, and J. Pile-Spellman Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis Neurology, December 23, 2003; 61(12): 1729 - 1735. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dichgans, B. Putz, D. Boos, and D. P. Auer Role of Subvoxel Free Fluid on Diffusion Parameters in Brain Tissue with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy and Its Correlation with Physical Disability: Histogram Analysis of Standard and Fluid-Attenuated MR Diffusion AJNR Am. J. Neuroradiol., June 1, 2003; 24(6): 1083 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tatsch, W. Koch, R. Linke, G. Poepperl, N. Peters, M. Holtmannspoetter, and M. Dichgans Cortical Hypometabolism and Crossed Cerebellar Diaschisis Suggest Subcortically Induced Disconnection in CADASIL: An 18F-FDG PET Study J. Nucl. Med., June 1, 2003; 44(6): 862 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
E H C Cup, W J M Scholte op Reimer, M C E Thijssen, and M A H van Kuyk-Minis Reliability and validity of the Canadian Occupat189ional Performance Measure in stroke patients Clinical Rehabilitation, April 1, 2003; 17(4): 402 - 409. [Abstract] [PDF] |
||||
![]() |
G A M van den Bos, J P J M Smits, G P Westert, and A van Straten Socioeconomic variations in the course of stroke: unequal health outcomes, equal care? J. Epidemiol. Community Health, December 1, 2002; 56(12): 943 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Molko, S. Pappata, J.-F. Mangin, F. Poupon, D. LeBihan, M.-G. Bousser, and H. Chabriat Monitoring Disease Progression in CADASIL With Diffusion Magnetic Resonance Imaging: A Study With Whole Brain Histogram Analysis Stroke, December 1, 2002; 33(12): 2902 - 2908. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. SHIOGAI, C. UEBO, M. MAKINO, T. MIZUNO, K. NAKAJIMA, and H. FURUHATA Acetazolamide Vasoreactivity in Vascular Dementia and Persistent Vegetative State Evaluated by Transcranial Harmonic Perfusion Imaging and Doppler Sonography Ann. N.Y. Acad. Sci., November 1, 2002; 977(1): 445 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. de Jong, F. Kessels, and J. Lodder Two Types of Lacunar Infarcts: Further Arguments From a Study on Prognosis Stroke, August 1, 2002; 33(8): 2072 - 2076. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hartmann, J. Pile-Spellman, C. Stapf, R.R. Sciacca, A. Faulstich, J.P. Mohr, H.C. Schumacher, and H. Mast Risk of Endovascular Treatment of Brain Arteriovenous Malformations Stroke, July 1, 2002; 33(7): 1816 - 1820. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J.M. Barnett, H. E. Meldrum, and M. Eliasziw The appropriate use of carotid endarterectomy Can. Med. Assoc. J., April 1, 2002; 166(9): 1169 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liebetrau, J. Herzog, C. U.A. Kloss, G. F. Hamann, and M. Dichgans Prolonged Cerebral Transit Time in CADASIL: A Transcranial Ultrasound Study Stroke, February 1, 2002; 33(2): 509 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cardol, B. A de Jong, G. A. van den Bos, A. Beelen, I. J M de Groot, and R. J de Haan Beyond disability: perceived participation in people with a chronic disabling condition Clinical Rehabilitation, January 1, 2002; 16(1): 27 - 35. [Abstract] [PDF] |
||||
![]() |
M. G. Celani, T. A. Cantisani, E. Righetti, L. Spizzichino, and S. Ricci Different Measures for Assessing Stroke Outcome: An Analysis From the International Stroke Trial in Italy Stroke, January 1, 2002; 33(1): 218 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Molko, S. Pappata, J.F. Mangin, C. Poupon, K. Vahedi, A. Jobert, D. LeBihan, M.G. Bousser, and H. Chabriat Diffusion Tensor Imaging Study of Subcortical Gray Matter in CADASIL Stroke, September 1, 2001; 32(9): 2049 - 2054. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bruening, M. Dichgans, C. Berchtenbreiter, T. Yousry, K. C. Seelos, R. H. Wu, M. Mayer, G. Brix, and M. Reiser Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: Decrease in Regional Cerebral Blood Volume in Hyperintense Subcortical Lesions Inversely Correlates with Disability and Cognitive Performance AJNR Am. J. Neuroradiol., August 1, 2001; 22(7): 1268 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Oliveira-Filho, M. A. Ezzeddine, A. Z. Segal, F. S. Buonanno, Y. Chang, C. S. Ogilvy, G. Rordorf, L. H. Schwamm, W. J. Koroshetz, and C. T. McDonald Fever in subarachnoid hemorrhage: Relationship to vasospasm and outcome Neurology, May 22, 2001; 56(10): 1299 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.A. Rocca, M. Filippi, J. Herzog, M.P. Sormani, M. Dichgans, and T.A. Yousry A magnetic resonance imaging study of the cervical cord of patients with CADASIL Neurology, May 22, 2001; 56(10): 1392 - 1394. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Auer, T. Schirmer, J. O. Heidenreich, J. Herzog, B. Putz, and M. Dichgans Altered white and gray matter metabolism in CADASIL: A proton MR spectroscopy and 1H-MRSI study Neurology, March 13, 2001; 56(5): 635 - 642. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Iannucci, M. Dichgans, M. Rovaris, R. Bruning, T. Gasser, L. Giacomotti, T.A. Yousry, and M. Filippi Correlations Between Clinical Findings and Magnetization Transfer Imaging Metrics of Tissue Damage in Individuals With Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Stroke, March 1, 2001; 32(3): 643 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Horn, R. J. de Haan, M. Vermeulen, and M. Limburg Very Early Nimodipine Use in Stroke (VENUS) : A Randomized, Double-Blind, Placebo-Controlled Trial Stroke, February 1, 2001; 32(2): 461 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Horn and M. Limburg Calcium Antagonists for Ischemic Stroke : A Systematic Review Stroke, February 1, 2001; 32(2): 570 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
|